ABOS
Acumen Pharmaceuticals Inc
2.20$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -401.8% | -518.8% | -1,250.8% | – | – | – | – | |
| 0.2% | 0.3% | 0.3% | – | – | – | – | |
| 10.3% | 10.7% | 64.2% | – | – | – | – | |
| 18.9% | -30.1% | 5,734.2% | – | – | – | – | |
| 45.3% | 21.4% | 20.8% | – | – | – | – | |
| 2.4% | 2.8% | 2.8% | – | – | – | – | |
| -6,135.5% | -7,250.7% | -7,250.7% | – | – | – | – | |
| – | – | 11,868.7% | – | – | – | – | |
| 367.6% | 3,111.1% | 13,960.0% | – | – | – | – | |
| -34.1% | 2,592.3% | 5,458.6% | – | – | – | – | |
| -401.8% | -518.8% | -1,253.6% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.